Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma

NCT01217229

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Northwestern University, The Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

NCT01854567

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +17 more
Locations
  • University of Miami Health System Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

NCT02812875

Conditions
Adenoma, Advanced Solid Tumors or Lymphomas, Hemic and Lymphatic Diseases, +10 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute Sarasota, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

NCT00824265

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Novartis Investigative Site Boca Raton, Florida, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Clinton, Maryland, United States
  • Novartis Investigative Site Kansas City, Missouri, United States
View all 135 locations
View Trial Details
Completed

LAM Pilot Study With Imatinib Mesylate

NCT03131999

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Columbia University New York, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Completed

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL

NCT02055820

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Central Coast Medical Oncology Santa Maria, California, United States
  • The West Clinici St Louis, Missouri, United States
View all 52 locations
View Trial Details
Completed

Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

NCT00939770

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 28 locations
View Trial Details

Related conditions